The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_177438.3(DICER1):c.4449G>A (p.Met1483Ile)

CA390868420

577152 (ClinVar)

Gene: DICER1
Condition: DICER1-related tumor predisposition
Inheritance Mode: Autosomal dominant inheritance
UUID: 7c2d7e8f-25f6-4005-b0cc-81f6f123334b
Approved on: 2024-01-09
Published on: 2024-01-17

HGVS expressions

NM_177438.3:c.4449G>A
NM_177438.3(DICER1):c.4449G>A (p.Met1483Ile)
NC_000014.9:g.95096471C>T
CM000676.2:g.95096471C>T
NC_000014.8:g.95562808C>T
CM000676.1:g.95562808C>T
NC_000014.7:g.94632561C>T
NG_016311.1:g.65952G>A
ENST00000343455.8:c.4449G>A
ENST00000393063.6:c.4449G>A
ENST00000526495.6:c.4449G>A
ENST00000532939.3:c.4449G>A
ENST00000556045.6:c.4449G>A
ENST00000675540.1:c.2194G>A
ENST00000675995.1:c.*2765G>A
ENST00000343455.7:c.4449G>A
ENST00000393063.5:c.4449G>A
ENST00000526495.5:c.4449G>A
ENST00000527414.5:c.4449G>A
ENST00000532939.2:c.484G>A
ENST00000541352.5:c.4449G>A
ENST00000556045.5:c.1143G>A
NM_001195573.1:c.4449G>A
NM_001271282.2:c.4449G>A
NM_001291628.1:c.4449G>A
NM_030621.4:c.4449G>A
NM_177438.2:c.4449G>A
NM_001271282.3:c.4449G>A
NM_001291628.2:c.4449G>A
NM_001395677.1:c.4449G>A
NM_001395678.1:c.4449G>A
NM_001395679.1:c.4449G>A
NM_001395680.1:c.4449G>A
NM_001395682.1:c.4449G>A
NM_001395683.1:c.4449G>A
NM_001395684.1:c.4449G>A
NM_001395685.1:c.4449G>A
NM_001395686.1:c.4167G>A
NM_001395687.1:c.4044G>A
NM_001395688.1:c.4044G>A
NM_001395689.1:c.4044G>A
NM_001395690.1:c.4044G>A
NM_001395691.1:c.3882G>A
NM_001395692.1:c.4449G>A
NM_001395693.1:c.4449G>A
NM_001395694.1:c.4449G>A
NM_001395695.1:c.4449G>A
NM_001395696.1:c.4044G>A
NM_001395697.1:c.2766G>A
NR_172715.1:n.4867G>A
NR_172716.1:n.5051G>A
NR_172717.1:n.4961G>A
NR_172718.1:n.4884G>A
NR_172719.1:n.4717G>A
NR_172720.1:n.4794G>A
More

Uncertain Significance

Met criteria codes 1
BP4
Not Met criteria codes 17
BA1 BS4 BS3 BS1 BS2 BP2 PS4 PS2 PS1 PS3 PP4 PP1 PP3 PM5 PM1 PM6 PM2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen DICER1 and miRNA-Processing Gene Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for DICER1 Version 1.2.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
DICER1 and miRNA-Processing Gene VCEP
The NM_177438.2:c.4449G>A variant in DICER1 is a missense variant predicted to cause substitution of methionine by isoleucine at amino acid 1483 (p.Met1483Ile). The highest population minor allele frequency in gnomAD v2.1.1 is 0.00005782 (2/34590 alleles) in the Admixed American population (PM2_Supporting, BS1, and BA1 are not met). In silico tools predict no damaging impact of the variant on protein function (REVEL: 0.039; MaxEntScan and SpliceAI: no effect on splicing) (BP4). In summary, this variant meets the criteria to be classified as Uncertain Significance for DICER1-related tumor predisposition based on the ACMG/AMP criteria applied, as specified by the ClinGen DICER1 VCEP: BP4. (Bayesian Points: -1; VCEP specifications version 1.2.0; 01/09/2024).
Met criteria codes
BP4
In silico tools predict no damaging impact of the variant on protein function (REVEL: 0.039; MaxEntScan and SpliceAI: no effect on splicing) (BP4).
Not Met criteria codes
BA1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM6
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM2
The highest population minor allele frequency in gnomAD v2.1.1 is 0.00005782 (2/34590 alleles) in the Admixed American population (PM2_Supporting, BS1, and BA1 are not met).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.